These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1469933)

  • 21. L-tryptophan and eosinophilia-myalgia syndrome.
    Shapiro S
    Lancet; 1994 Sep; 344(8925):817-9. PubMed ID: 7916094
    [No Abstract]   [Full Text] [Related]  

  • 22. L-tryptophan: eosinophilia-myalgia syndrome.
    D'Arcy PF
    Adverse Drug React Toxicol Rev; 1995; 14(1):37-43. PubMed ID: 7612781
    [No Abstract]   [Full Text] [Related]  

  • 23. Eosinophilia-myalgia syndrome: lessons for public health researchers.
    Taylor R; McNeil JJ
    Med J Aust; 1993 Jan; 158(1):51-5. PubMed ID: 8380218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-tryptophan and eosinophilia-myalgia syndrome.
    Mitchell N
    Med J Aust; 1993 Mar; 158(5):363-4. PubMed ID: 8329035
    [No Abstract]   [Full Text] [Related]  

  • 25. Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome.
    Klarskov K; Gagnon H; Racine M; Boudreault PL; Normandin C; Marsault E; Gleich GJ; Naylor S
    Toxicol Lett; 2018 Sep; 294():193-204. PubMed ID: 29800716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and analysis of contaminants in ems-related tryptophan.
    Steinhart H; van Wickern B; Meyer K; Simat T
    Adv Exp Med Biol; 1996; 398():667-75. PubMed ID: 8906342
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
    Cilursu AM; Goeken J; Olson RR
    Ann Rheum Dis; 1991 Nov; 50(11):817-9. PubMed ID: 1772299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
    Keating JP; Wardill K; Viggiano J
    N Z Med J; 1992 Aug; 105(939):317. PubMed ID: 1386918
    [No Abstract]   [Full Text] [Related]  

  • 29. Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia?
    Hudson JI; Pope HG; Daniels SR; Horwitz RI
    JAMA; 1993 Jun 23-30; 269(24):3108-9. PubMed ID: 8505810
    [No Abstract]   [Full Text] [Related]  

  • 30. [L-tryptophan-induced eosinophilia-myalgia syndrome, Chinese restaurant syndrome].
    Terao T; Hori H; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):650-3. PubMed ID: 10434740
    [No Abstract]   [Full Text] [Related]  

  • 31. The lessons of eosinophilia-myalgia syndrome.
    Duffy J
    Hosp Pract (Off Ed); 1992 Apr; 27(4A):65-9, 73-80, 83-90. PubMed ID: 1560091
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome.
    Williamson BL; Tomlinson AJ; Hurth KM; Posada de la Paz M; Gleich GJ; Naylor S
    Biomed Chromatogr; 1998; 12(5):255-61. PubMed ID: 9787895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for contaminant in EMS outbreak goes slowly.
    Swinbanks D; Anderson C
    Nature; 1992 Jul; 358(6382):96. PubMed ID: 1614552
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome.
    Driskell WJ; Ashley DL; Grainger J; Sirimanne SR; Mazzola EP; Page SW; Needham LL; Hill RH
    Bull Environ Contam Toxicol; 1992 May; 48(5):679-87. PubMed ID: 1504513
    [No Abstract]   [Full Text] [Related]  

  • 35. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
    Clauw DJ; Pincus T
    J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175
    [No Abstract]   [Full Text] [Related]  

  • 36. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
    Bournerias I; Castot A
    Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247
    [No Abstract]   [Full Text] [Related]  

  • 37. Tryptophan induced eosinophilia-myalgia syndrome: clinical and microscopic findings.
    Groves RW; Simpson KJ; Koblar S; Pitzalis C; Hay RJ
    J R Soc Med; 1992 Feb; 85(2):111-2. PubMed ID: 1538375
    [No Abstract]   [Full Text] [Related]  

  • 38. [Peripheral neuropathy unmasked by therapy with adrenal cortex hormones during myalgia-eosinophilia syndrome related to L-tryptophan].
    Moreaud O; Mezin P; De Saint Victor JF; Noelle B; Berger F; Pellat J
    Presse Med; 1994 Jun; 23(24):1138. PubMed ID: 7971839
    [No Abstract]   [Full Text] [Related]  

  • 39. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
    Kilbourne EM; Philen RM; Kamb ML; Falk H
    J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and formation of an EMS correlated contaminant in biotechnologically manufactured L-tryptophan.
    Müller B; Pacholski C; Simat T; Steinhart H
    Adv Exp Med Biol; 1999; 467():481-6. PubMed ID: 10721091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.